https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-may-be-superior-pfizer-against-delta-breakthrough-odds-rise-with-time-2021-08-09/"In a study of more than 50,000 patients in the Mayo Clinic Health System, researchers found the effectiveness of Moderna's vaccine against infection had dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021. Over the same period, the effectiveness of the Pfizer/BioNTech vaccine had fallen to 42% from 76%, researchers said."
Quotes in a signature is annoying, as it comes across as an independent post.
Wow. Also, 86% and 76%? Huh? Weren’t they 94% and 95%?
That was pre-Delta.Better question is why isn't Israel using Moderna for the booster.
They’re saying Moderna and Pfizer were respectively only 86% and 76% pre-Delta.
They’re saying Moderna and Pfizer were respectively only 86% and 76% pre-Delta.Now at 76% and 42%.
Maybe this is Mayo's own data, while the 94-95% were from the companies?
Wasn't Pfizer approved and administered earlier?
That's my assumption. Still interesting that such a variance exists and that we didn't hear about it.
any data on JJ/Delta?
Wonder with pfizer being the more dominant vaccine is that why the virus mutated around it?
What about natural antibodies boosted by Moderna?
The article we talked about yesterday, about reinfections in Kentucky https://forums.dansdeals.com/index.php?topic=126089.0 studied 50 people who had natural antibodies from a covid infection in 2020 then were vaccinated in 2021 with either J&J, Pfizer or Moderna, then were reinfected in May-June. Their discussion didn't touch on the brands, so I would assume that it wasn't a large enough group to conclude that any one brand was a more effective booster.
Not only does it not mention the brand, it has no indication of weather one or two doses of vaccine were given, or antibody levels prior to vaccine, and after vaccine.